LYB
32
2
GILD
50
13
SWN
30
-12
UNP
50
4
KHC
29
2
CMA
39
3
OI
26
-2
RIG
28
2
MOS
22
2
MAT
50
18
CHK
5
-7
ADM
36
2
PRU
50
2
NWS
77
8
SRE
30
-2
HAS
49
3
SO
70
-3
NWL
32
4
HST
40
2
KMI
55
-4
LYB
32
2
GILD
50
13
SWN
30
-12
UNP
50
4
KHC
29
2
CMA
39
3
OI
26
-2
RIG
28
2
MOS
22
2
MAT
50
18
CHK
5
-7
ADM
36
2
PRU
50
2
NWS
77
8
SRE
30
-2
HAS
49
3
SO
70
-3
NWL
32
4
HST
40
2
KMI
55
-4
Financhill
Back

Iteris Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
48

ITI
Iteris

Last Price:
4.08
Seasonality Move:
3.07%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
48
Iteris (ITI) is a Sell

Is Iteris a Buy, Sell or Hold?

  • The current Iteris [ITI] share price is $4.08. The Score for ITI is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • ITI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ITI Stock Price Chart

What is Iteris's stock price today?

  • The Iteris share price today is $4.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITI is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

ITI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 31.51 Sell
Chaikin Money Flow: -126486 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.3 - 4.62) Sell
Bollinger Bands (100): (4.46 - 5.02) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

ITI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.26 Sell
20-day SMA: 4.41 Sell
50-day SMA: 4.52 Sell
200-day SMA: 4.61 Sell
8-day EMA: 4.25 Sell
20-day EMA: 4.37 Sell
50-day EMA: 4.51 Sell
200-day EMA: 4.57 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Iteris Earnings Growth & ITI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.42 per share, and an increase next year of $0.06 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Iteris Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):